HyperBranch Medical

Durham, United States Founded: 2003 • Age: 23 yrs Acquired By Stryker
Biosurgical devices are developed using proprietary polymers and hydrogels.
Request Access

About HyperBranch Medical

HyperBranch Medical is a company based in Durham (United States) founded in 2003 was acquired by Stryker in October 2018.. HyperBranch Medical has raised $18.69 million across 9 funding rounds from investors including Stryker, The Aurora Funds and H.I.G. Capital. HyperBranch Medical operates in a competitive market with competitors including Adhezion Biomedical, BRIJ Medical, BORAYER, Inno Therapy and Mussel Polymers, among others.

  • Headquarter Durham, United States
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Medical Devices & Diagnostics
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $18.69 M (USD)

    in 9 rounds

  • Latest Funding Round
    $2 M (USD), Series A

    Jun 01, 2013

  • Investors
    Stryker

    & 2 more

  • Employee Count
    Employee Count
  • Acquired by
    Stryker

    (Oct 01, 2018)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of HyperBranch Medical

HyperBranch Medical has successfully raised a total of $18.69M across 9 strategic funding rounds. The most recent funding activity was a Series A round of $2 million completed in June 2013. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 9
  • Last Round Series A — $2.0M
  • First Round

    (25 Jan 2005)

  • Investors Count 2
Date Amount Transaction Name Valuation Lead Investors Investors
Jun, 2013 Amount Series A - HyperBranch Medical Valuation

investors

May, 2013 Amount Series A - HyperBranch Medical Valuation

investors

May, 2012 Amount Series A - HyperBranch Medical Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in HyperBranch Medical

HyperBranch Medical has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include Stryker, The Aurora Funds and H.I.G. Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
-
Founded Year Domain Location
Private equity capital is invested in small and mid-sized businesses.
Founded Year Domain Location
3D-printed orthopedic products are manufactured for medical applications.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by HyperBranch Medical

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - HyperBranch Medical

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Hyperbranch Medical Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of HyperBranch Medical

HyperBranch Medical operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Adhezion Biomedical, BRIJ Medical, BORAYER, Inno Therapy and Mussel Polymers, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Developer of cyanoacrylate based surgical, wound management, and infection prevention products
domain founded_year HQ Location
Medical devices for post-surgical and trauma incision care are provided.
domain founded_year HQ Location
Biomaterials for surgery and wound repair are developed.
domain founded_year HQ Location
Hemostatic polymers are produced for surgical and wound care applications.
domain founded_year HQ Location
Adhesive solutions are manufactured for diverse materials and applications.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Hyperbranch Medical

Frequently Asked Questions about HyperBranch Medical

When was HyperBranch Medical founded?

HyperBranch Medical was founded in 2003 and raised its 1st funding round 2 years after it was founded.

Where is HyperBranch Medical located?

HyperBranch Medical is headquartered in Durham, United States. It is registered at Durham, North Carolina, United States.

Is HyperBranch Medical a funded company?

HyperBranch Medical is a funded company, having raised a total of $18.69M across 9 funding rounds to date. The company's 1st funding round was a Series A of $1.94M, raised on Jan 25, 2005.

What does HyperBranch Medical do?

HyperBranch Medical is focused on biosurgical devices based on its proprietary polymers and cross-linked hydrogels. Initial focus is on the surgical sealant market. Lead product is the Adherus AutoSpray Dural Sealant, used to provide closure during surgical procedures. Licensed its liquid ocular bandage technology to Becton Dickinson in 2009. Approved by FDA in Mar 2015 and received CE Mark in 2012.

Who are the top competitors of HyperBranch Medical?

HyperBranch Medical's top competitors include Adhezion Biomedical, BRIJ Medical and Inno Therapy.

Who are HyperBranch Medical's investors?

HyperBranch Medical has 3 investors. Key investors include Stryker, The Aurora Funds, and H.I.G. Capital.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available